The Enterprise Value as of September 2024 (TTM) for Harpoon Therapeutics, Inc. (HARP) is 861.85M

According to Harpoon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 861.85M. This represents a change of -46540.08% compared to the average of -1855822.41 of the last 4 quarters.

Harpoon Therapeutics, Inc. (HARP) Historical Enterprise Value (quarterly & annually)

How has HARP Enterprise Value performed in the past?

The mean historical Enterprise Value of Harpoon Therapeutics, Inc. over the last ten years is 342.50M. The current 861.85M Enterprise Value has changed 25.06% with respect to the historical average. Over the past ten years (40 quarters), HARP's Enterprise Value was at its highest in in the December 2017 quarter at 1.25B. The Enterprise Value was at its lowest in in the March 2023 quarter at -18275651.76.

Harpoon Therapeutics, Inc. (HARP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Harpoon Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Harpoon Therapeutics, Inc. (HARP) Average Enterprise Value

How has HARP Enterprise Value performed in the past?

The current Enterprise Value of Harpoon Therapeutics, Inc. (HARP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Harpoon Therapeutics, Inc. (HARP) Enterprise Value vs. Peers

How is HARP’s Enterprise Value compared to its peers?

Harpoon Therapeutics, Inc.’s Enterprise Value is greater than Passage Bio, Inc. (44.87M), greater than Black Diamond Therapeutics, Inc. (296.10M), greater than TCR2 Therapeutics Inc. (49.64M), greater than Alector, Inc. (460.58M), greater than Stoke Therapeutics, Inc. (586.20M), greater than Homology Medicines, Inc. (-103303255.00), less than Adaptimmune Therapeutics plc (0), greater than Revolution Medicines, Inc. (114.25M), less than Atreca, Inc. (6.80B), greater than null (-8620212.00),

Build a custom stock screener for Harpoon Therapeutics, Inc. (HARP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Harpoon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Harpoon Therapeutics, Inc. (HARP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Harpoon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.